| G9137 | Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project) |
| G9019 | Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) |
| G9035 | Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) |
| G9020 | Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project) |
| G9036 | Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project) |
| G9152 | Mapcp demonstration - community health teams |
